AI supported in silico screening of chimeric antigen receptor therapy targets
Giorgia Moranzoni, Lasse Vedel Jørgensen, Javier Herranz del Cerro…·Lars Rønn Olsen
The paper presents a framework integrating AI and computational tools to evaluate CAR target characteristics, using HER2 as a case study to identify liabilities beyond conventional expression analysis.